A chemical perspective on the clinical use of platinum-based anticancer drugs
S Alassadi, MJ Pisani, NJ Wheate - Dalton Transactions, 2022 - pubs.rsc.org
Platinum drugs have been a mainstay of cancer chemotherapy since the introduction of
cisplatin in the 1970s. Since then, carboplatin and oxaliplatin have been approved world …
cisplatin in the 1970s. Since then, carboplatin and oxaliplatin have been approved world …
Recent advancements in Nanotechnology-Mediated Platinum-Based cancer therapy
Abstract The utilization of Platinum (Pt)-based drugs has significantly transformed the
landscape of cancer chemotherapy, serving as highly effective anticancer agents. However …
landscape of cancer chemotherapy, serving as highly effective anticancer agents. However …
Pt (IV) prodrugs with non-steroidal anti-inflammatory drugs in the axial position
DV Spector, KG Pavlov, RA Akasov… - Journal of Medicinal …, 2022 - ACS Publications
We report herein the design, synthesis, and biological investigation of a series of novel Pt
(IV) prodrugs with non-steroidal anti-inflammatory drugs naproxen, diclofenac, and …
(IV) prodrugs with non-steroidal anti-inflammatory drugs naproxen, diclofenac, and …
Targeting the gut microbiome to control drug pharmacomicrobiomics: The next frontier in oral drug delivery
Introduction The trillions of microorganisms that comprise the gut microbiome form dynamic
bidirectional interactions with orally administered drugs and host health. These relationships …
bidirectional interactions with orally administered drugs and host health. These relationships …
Computational strategies to model the interaction and the reactivity of biologically-relevant transition metal complexes
I Tolbatov, A Marrone - Inorganica Chimica Acta, 2022 - Elsevier
Transition metal atoms possess the unique capacity to induce significant changes in the
electronic structure of their ligands, often culminating in substantial modification of their …
electronic structure of their ligands, often culminating in substantial modification of their …
The protein-binding behavior of platinum anticancer drugs in blood revealed by mass spectrometry
J Wang, J Tao, S Jia, M Wang, H Jiang, Z Du - Pharmaceuticals, 2021 - mdpi.com
Cisplatin and its analogues are widely used as chemotherapeutic agents in clinical practice.
After being intravenously administrated, a substantial amount of platinum will bind with …
After being intravenously administrated, a substantial amount of platinum will bind with …
[HTML][HTML] Metallodrug binding to serum albumin: Lessons from biophysical and structural studies
A Merlino - Coordination Chemistry Reviews, 2023 - Elsevier
Human serum albumin (HSA) plays a major role in the transport of metallodrugs, affecting
pharmacokinetics and pharmacodynamics of these molecules. This work highlights the …
pharmacokinetics and pharmacodynamics of these molecules. This work highlights the …
A phase I dose escalation study of oxaliplatin, cisplatin and doxorubicin applied as PIPAC in patients with peritoneal carcinomatosis
M Robella, M De Simone, P Berchialla, M Argenziano… - Cancers, 2021 - mdpi.com
Simple Summary This study is one of the very few phase I trials on intraperitoneal
chemotherapy applied as PIPAC. Cisplatin and doxorubicin may be safely used as PIPAC at …
chemotherapy applied as PIPAC. Cisplatin and doxorubicin may be safely used as PIPAC at …
Nanoparticles Containing Oxaliplatin and the Treatment of Colorectal Cancer
H Mahaki, M Mansourian, Z Meshkat… - Current …, 2023 - ingentaconnect.com
Background: Colorectal cancer (CRC) is a highly widespread malignancy and ranks as the
second most common cause of cancer-related mortality. Objective: Cancer patients …
second most common cause of cancer-related mortality. Objective: Cancer patients …
Newly synthesized palladium (II) complexes with aminothiazole derivatives: in vitro study of antimicrobial activity and antitumor activity on the human prostate cancer …
D Simić, M Zarić, I Nikolić, R Živković-Zarić… - Dalton …, 2022 - pubs.rsc.org
Five new complexes of the palladium (II) ion (C1–C5) having the general formula [(PdL2)]
Cl2 with some 2-aminothiazoles (L1–L5), where L1= 2-amino-4-(3, 4-difluorophenyl) …
Cl2 with some 2-aminothiazoles (L1–L5), where L1= 2-amino-4-(3, 4-difluorophenyl) …